company insight

TSS

The life science industry faces many new challenges moving forward. The need to save costs, meet regulations and implement sustainability initiatives has never been greater. Transforming your supply chain with our cloud temperature management solution can help you meet these challenges and achieve measurable ROI. It delivers big data-driven analytics, and documents end-to-end visibility of drugs as they move through the supply chain. This ensure compliance with regulators’ monitoring requirements, while minimizing administrative paperwork.

Transform End-to-End drug delivery with powerful Analytics and Insights

SHL Group details its approach to the challenges of emerging formulations

With Pharma for pharma

TSS Cloud temperature management solution, which comes with 20-years of drug distribution data and best practices, has been developed with some of the world’s leading pharmaceutical companies. They use it on a daily basis to guarantee drugs are delivered safely to patients, improve the performance of service providers, streamline the delivery process, and identify and implement sustainability initiatives. For many of them it has become a key component of their risk-based approach to managing the supply chain.

Powerful analytics

The secure software is tracker-independent. It can be incorporated into an existing ERP system or run separately on any computer or device. It can be tailored to meet the requirements of your operation – no matter where you are in the product life cycle – to gain key insights that drive competitive advantage. You can compare everything from shipment routes and modes of transport to freight forwarder performance, and the impact different packaging has on a drug.

Always at Your Service

TSS intuitive analytics tools capture and secure big data and present it in easy to read dashboards to manage and transform your supply chain. Our expert team can provide the support you need to interpret data and identify initiatives to reduce unnecessary costs in your drug delivery process. They have experience from working with millions of successful missions, for 20,000 users in 100 plus countries. Together with our clients all around the world they help manufactures identify millions of dollars in annual savings and help clinical trial companies minimize over production of drugs, among many other valuable things.

The Future-proof Solution

Contact information:

TSS AB

Email: customer.service@tss.se

Website: www.tss.se

Go to top

Share this article

Go to article: Home | Gut InstinctGo to article: In this issueGo to article: TSS Company InsightGo to article: TSS ABGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: Scandinavian Health Ltd.Go to article: The Pharma Industry BriefingGo to article: Komtur PharmaceuticalsGo to article: Komtur Pharmaceuticals Company InsightGo to article: How will the UK’s relaxed cannabis regulations impact clinical practice?Go to article: Finnair CargoGo to article: Finnair Cargo | Company InsightGo to article: Developing a new class of cancer combo drugsGo to article: Phoenix Company InsightGo to article: PhoenixGo to article: Antidepressants in the environment: combatting pharmaceutical pollutionGo to article: AtoZ-CRO GmbHGo to article: AtoZ-CRO GmbH Company InsightGo to article: Christensella: the key to unlocking gut microbiome-based drug discovery?Go to article: CBDepotGo to article: CBDepot Company InsightGo to article: Going digital to improve clinical trial enrolmentGo to article: BEAGo to article: Incretin combination therapy: a breakthrough for type 2 diabetes?Go to article: AlpexGo to article: Ebola in the DRC: vaccinating in a conflict zoneGo to article: Hemp IndustriesGo to article: Unither PharmaceuticalsGo to article: Data overload: turning challenges into opportunities in clinical trialsGo to article: ZenatekGo to article: Solving clinical research challenges: an IT perspectiveGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: EventsGo to article: In the next issue